Clinical application of GLP-1 in atherosclerosis There is substantial evidence that GLP-1 is involved in the function of the cardiovascular system [9]
Alzheimers disease (Reduce attention deficiencies in some individuals after long-term treatment, especially when combined with acetylcholinesterase inhibitors ) Depression (Acetyl L-Carnitine supplement remarkably decrease depression symptoms) HIV infection (used for symptomatic management and nerve regeneration) Diabetic Neuropathy (Reduce pain, Enhance nerve conduction velocity, and nerve regeneration) Ischemia (acts as neuroprotective) Cognitive impairment due to alcohol abuse
Allen notes there are still other paths worth exploring: "If they are not covered, then we can look at any existing 'coupons' or discounts, for example, buying directly from the pharmaceutical companies, which are Novo Nordisk for Wegovy (semaglutide) and Eli Lilly for Zepbound (tirzepatide)." However, coverage for diabetes is typically better than for just weight loss, which can make it easier to get medications like semaglutide or tirzepatide
While nearly all this research involves animal models, the consistency of results across different injury types and body systems has generated significant interest in the peptide therapy community
:max_bytes(150000):strip_icc()/VWH_NEWS_GLP1_TastePerception-579dc0e01a604949af26d0e23e75b7fc.png)
